Tag: pcdna6 2

In situ strategy for biomedical target localization via nanogold nucleation and secondary growth

In situ strategy for biomedical target localization via nanogold nucleation and secondary growthIn situ strategy for biomedical target localization via nanogold nucleation and secondary growth

| ColeCole | 0 Comment

Immunocytochemistry visualizes the precise spatial location of goal molecules. The most typical technique for ultrastructural immunocytochemistry is the conjugation of nanogold particles to antibodies as probes. Nonetheless, typical nanogold labelling requires time-consuming

READ MOREREAD MORE
Iodine-Mediated Etching of Gold Nanorods for Plasmonic ELISA Based on Colorimetric Detection of Alkaline Phosphatase.

Iodine-Mediated Etching of Gold Nanorods for Plasmonic ELISA Based on Colorimetric Detection of Alkaline Phosphatase.Iodine-Mediated Etching of Gold Nanorods for Plasmonic ELISA Based on Colorimetric Detection of Alkaline Phosphatase.

| ColeCole | 0 Comment

Right here, we suggest a plasmonic enzyme-linked immunosorbent assay (ELISA) primarily based on extremely delicate colorimetric detection of alkaline phosphatase (ALP), which is achieved by iodine-mediated etching of gold nanorods

READ MOREREAD MORE
A recombinant antibody fragment directed to the thymic stromal lymphopoietin receptor (CRLF2) efficiently targets pediatric Philadelphia chromosome-like acute lymphoblastic leukemia

A recombinant antibody fragment directed to the thymic stromal lymphopoietin receptor (CRLF2) efficiently targets pediatric Philadelphia chromosome-like acute lymphoblastic leukemiaA recombinant antibody fragment directed to the thymic stromal lymphopoietin receptor (CRLF2) efficiently targets pediatric Philadelphia chromosome-like acute lymphoblastic leukemia

| ColeCole | 0 Comment

Antibody fragments are promising constructing blocks for creating focused therapeutics, thus enhancing remedy efficacy whereas minimising off-target toxicity. Regardless of latest advances in focused therapeutics, sufferers with Philadelphia-like acute lymphoblastic leukemia

READ MOREREAD MORE
A GFP expressing influenza A virus to report in vivo tropism and protection by a matrix protein 2 ectodomain-specific monoclonal antibody.

A GFP expressing influenza A virus to report in vivo tropism and protection by a matrix protein 2 ectodomain-specific monoclonal antibody.A GFP expressing influenza A virus to report in vivo tropism and protection by a matrix protein 2 ectodomain-specific monoclonal antibody.

| ColeCole | 0 Comment

The severity of influenza-related sickness is mediated by many elements, together with in vivo cell tropism, timing and magnitude of the immune response, and presence of pre-existing immunity. A direct

READ MOREREAD MORE